Neuropathological mechanisms of seizures in autism spectrum disorder

Frontiers in Neuroscience

Volumn 10, Issue MAY, 2016, Pages

  Frye, Richard E ^a,b   Casanova, Manuel F ^c   Fatemi, S Hossein ^d   Folsom, Timothy D ^d   Reutiman, Teri J ^d   Brown, Gregory L ^e   Edelson, Stephen M ^f   Slattery, John C ^a,b   Adams, James B ^g  

^a ARKANSAS CHILDREN S HOSPITAL RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE GREENVILLE   (United States)

^d UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^e Serenity Health Care Center   (United States)

^f Autism Research Institute   (United States)

^g Arizona State University   (United States)

Author keywords

Autism spectrum disorder; Epilepsy; Excitatory to inhibitory cortical balance; Gamma aminobutyric acid; Genetic syndrome; Metabolic disorders; Seizures

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID B RECEPTOR; 4 AMINOBUTYRIC ACID RECEPTOR; GLUTAMIC ACID; HEAVY METAL; METABOTROPIC RECEPTOR 5; PYRIDOXINE; SUCCINATE SEMIALDEHYDE DEHYDROGENASE; UREA;

4 AMINOBUTYRIC ACID METABOLISM; AUTISM; AUTOPSY; BRAIN CORTEX; DISEASE ASSOCIATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENERGY METABOLISM; ENZYME DEFICIENCY; FRAGILE X SYNDROME; GABAERGIC SYSTEM; GABAERGIC TRANSMISSION; GENETIC DISORDER; GLUTAMATE NEUROTRANSMISSION; HAPPY PUPPET SYNDROME; HISTOPATHOLOGY; HUMAN; IMMUNOPATHOLOGY; INTERNEURON; METABOLIC DISORDER; MINERAL DEFICIENCY; NERVE CELL EXCITABILITY; NERVE CELL INHIBITION; NERVE CELL NETWORK; NEUROPATHOLOGY; NEUROPIL; NEUROTRANSMISSION; NONHUMAN; PHENYLKETONURIA; PREVALENCE; PROTEIN EXPRESSION; PROTEIN SUBUNIT; RETT SYNDROME; SEIZURE; SHORT SURVEY; UREA CYCLE; VITAMIN DEFICIENCY;

EID: 84973551308     PISSN: 16624548     EISSN: 1662453X     Source Type: Journal    
DOI: 10.3389/fnins.2016.00192     Document Type: Short Survey

References (143)

1. Adams, J. B., Audhya, T., McDonough-Means, S., Rubin, R. A., Quig, D., Geis, E., et al. (2011). Effect of a vitamin/mineral supplement on children and adults with autism. BMC Pediatr. 11:111. doi: 10.1186/1471-2431-11-111
2. Akaike, A., Tamura, Y., Sato, Y., and Yokota, T. (1993). Protective effects of a vitamin B12 analog, methylcobalamin, against glutamate cytotoxicity in cultured cortical neurons. Eur. J. Pharmacol. 241, 1-6. doi: 10.1016/0014-2999(93)90925-8
3. Anderson, M. P., Hooker, B. S., and Herbert, M. R. (2008). Bridging from cells to cognition in autism pathophysiology: biological pathways to defective brain function and plasticity Am. J. Biochem. Biotechnol. 4, 167-176. doi: 10.3844/ajbbsp.2008.167.176
4. Arrieta, O., Palencia, G., García-Arenas, G., Morales-Espinosa, D., Hernández-Pedro, N., and Sotelo, J. (2005). Prolonged exposure to lead lowers the threshold of pentylenetetrazole-induced seizures in rats. Epilepsia 46, 1599-1602. doi: 10.1111/j.1528-1167.2005.00267.x
5. Ault, B., Evans, R. H., Francis, A. A., Oakes, D. J., and Watkins, J. C. (1980). Selective depression of excitatory amino acid induced depolarizations by magnesium ions in isolated spinal cord preparations. J. Physiol. 307, 413-428. doi: 10.1113/jphysiol.1980.sp013443
6. Baieli, S., Pavone, L., Meli, C., Fiumara, A., and Coleman, M. (2003). Autism and phenylketonuria. J. Autism Dev. Disord. 33, 201-204. doi: 10.1023/A:1022999712639
7. Bangash, M. A., Park, J. M., Melnikova, T., Wang, D., Jeon, S. K., Lee, D., et al. (2011). Enhanced polyubiquitination of Shank3 and NMDA receptor in a mouse model of autism. Cell 145, 758-772. doi: 10.1016/j.cell.2011.03.052
8. Belyaeva, E. A., Korotkov, S. M., and Saris, N. E. (2011). In vitro modulation of heavy metal-induced rat liver mitochondria dysfunction: a comparison of copper and mercury with cadmium. J. Trace Elem. Med. Biol. 25(Suppl. 1), S63-S73. doi: 10.1016/j.jtemb.2010.10.007
9. Benbir, G., Uysal, S., Saltik, S., Zeybek, C. A., Aydin, A., Dervent, A., et al. (2007). Seizures during treatment of Vitamin B12 deficiency. Seizure 16, 69-73. doi: 10.1016/j.seizure.2006.10.016
10. Blanc, F., Ruppert, E., Kleitz, C., Valenti, M. P., Cretin, B., Humbel, R. L., et al. (2009). Acute limbic encephalitis and glutamic acid decarboxylase antibodies: a reality? J. Neurol. Sci. 287, 69-71. doi: 10.1016/j.jns.2009.09.004
11. Blatt, G. J., Fitzgerald, C. M., Guptill, J. T., Booker, A. B., Kemper, T. L., and Bauman, M. L. (2001). Density and distribution of hippocampal neurotransmitter receptors in autism: an autoradiographic study. J. Autism Dev. Disord. 31, 537-543. doi: 10.1023/A:1013238809666
12. Brock, J., Brown, C. C., Boucher, J., and Rippon, G. (2002). The temporal binding deficit hypothesis of autism. Dev. Psychopathol. 14, 209-224. doi: 10.1017/S0954579402002018
13. Brown, C., Gruber, T., Boucher, J., Rippon, G., and Brock, J. (2005). Gamma abnormalities during perception of illusory figures in autism. Cortex 41, 364-376. doi: 10.1016/S0010-9452(08)70273-9
14. Buxhoeveden, D. P., and Casanova, M. F. (2002). The minicolumn hypothesis in neuroscience. Brain 125, 935-951. doi: 10.1093/brain/awf110
15. Casanova, M. F., Buxhoeveden, D., and Gomez, J. (2003). Disruption in the inhibitory architecture of the cell minicolumn: implications for autism. Neuroscientist 9, 496-507. doi: 10.1177/1073858403253552
16. Casanova, M., Van Kooten, I., Switala, A., Van Engeland, H., Heinsen, H., Steinbusch, H., et al. (2006). Abnormalities of cortical minicolumnar organization in the prefrontal lobes of autistic patients. Clin. Neurosci. Res. 6, 127-133. doi: 10.1016/j.cnr.2006.06.003
17. Chaistitwanich, R., Mahoney, A. W., Hendricks, D. G., and Sisson, D. V. (1987). Dietary calcium and phosphorus and seizure susceptibility of magnesium deficient rats. Pharmacol. Biochem. Behav. 27, 443-449. doi: 10.1016/0091-3057(87)90347-9
18. Chen, H., and Chan, D. C. (2009). Mitochondrial dynamics-fusion, fission, movement, and mitophagy-in neurodegenerative diseases. Hum. Mol. Genet. 18, R169-R176. doi: 10.1093/hmg/ddp326
19. Clement, J. P., Aceti, M., Creson, T. K., Ozkan, E. D., Shi, Y., Reish, N. J., et al. (2012). Pathogenic SYNGAP1 mutations impair cognitive development by disrupting maturation of dendritic spine synapses. Cell 151, 709-723. doi: 10.1016/j.cell.2012.08.045
20. Cohen-Kfir, E., Lee, W., Eskandari, S., and Nelson, N. (2005). Zinc inhibition of gamma-aminobutyric acid transporter 4 (GAT4) reveals a link between excitatory and inhibitory neurotransmission. Proc. Natl. Acad. Sci. U.S.A. 102, 6154-6159. doi: 10.1073/pnas.0501431102
21. Cole, T. B., Robbins, C. A., Wenzel, H. J., Schwartzkroin, P. A., and Palmiter, R. D. (2000). Seizures and neuronal damage in mice lacking vesicular zinc. Epilepsy Res. 39, 153-169. doi: 10.1016/S0920-1211(99)00121-7
22. Condie, J., Goldstein, J., and Wainwright, M. S. (2010). Acquired microcephaly, regression of milestones, mitochondrial dysfunction, and episodic rigidity in a 46, XY male with a de novo MECP2 gene mutation. J. Child Neurol. 25, 633-636. doi: 10.1177/0883073809342004
23. Connolly, A. M., Chez, M. G., Pestronk, A., Arnold, S. T., Mehta, S., and Deuel, R. K. (1999). Serum autoantibodies to brain in Landau-Kleffner variant, autism, and other neurologic disorders. J. Pediatr. 134, 607-613. doi: 10.1016/S0022-3476(99)70248-9
24. Connolly, A. M., Chez, M., Streif, E. M., Keeling, R. M., Golumbek, P. T., Kwon, J. M., et al. (2006). Brain-derived neurotrophic factor and autoantibodies to neural antigens in sera of children with autistic spectrum disorders, Landau-Kleffner syndrome, and epilepsy. Biol. Psychiatry 59, 354-363. doi: 10.1016/j.biopsych.2005.07.004
25. Danielsson, S., Gillberg, I. C., Billstedt, E., Gillberg, C., and Olsson, I. (2005). Epilepsy in young adults with autism: a prospective population-based follow-up study of 120 individuals diagnosed in childhood. Epilepsia 46, 918-923. doi: 10.1111/j.1528-1167.2005.57504.x
26. Deepmala, Slattery, J., Kumar, N., Delhey, L., Berk, M., Dean, O., et al. (2015). Clinical trials of N-acetylcysteine in psychiatry and neurology: a systematic review. Neurosci. Biobehav. Rev. 55, 294-321. doi: 10.1016/j.neubiorev.2015.04.015
27. Defelipe, J. (1999). Chandelier cells and epilepsy. Brain 122(Pt 10), 1807-1822. doi: 10.1093/brain/122.10.1807
28. Defelipe, J. (2005). "Reflections on the structure of the cortical minicolumn, " in Neocortical Modularity and the Cell Minicolumn, ed M. F. Casanova (New York, NY: Nova Biomedical), 57-92.
29. Defelipe, J., Hendry, S. H., Hashikawa, T., Molinari, M., and Jones, E. G. (1990). A microcolumnar structure of monkey cerebral cortex revealed by immunocytochemical studies of double bouquet cell axons. Neuroscience 37, 655-673. doi: 10.1016/0306-4522(90)90097-N
30. Delgado-Escueta, A. V. (2007). Advances in genetics of juvenile myoclonic epilepsies. Epilepsy Curr. 7, 61-67. doi: 10.1111/j.1535-7511.2007.00171.x
31. Delorenzo, R. J. (1986). A molecular approach to the calcium signal in brain: relationship to synaptic modulation and seizure discharge. Adv. Neurol. 44, 435-464.
32. Delorenzo, R. J., and Limbrick, D. D. Jr. (1996). Effects of glutamate on calcium influx and sequestration/extrusion mechanisms in hippocampal neurons. Adv. Neurol. 71, 37-46.
33. Deykin, E. Y., and Macmahon, B. (1979). The incidence of seizures among children with autistic symptoms. Am. J. Psychiatry 136, 1310-1312. doi: 10.1176/ajp.136.10.1310
34. Dhossche, D., Applegate, H., Abraham, A., Maertens, P., Bland, L., Bencsath, A., et al. (2002). Elevated plasma gamma-aminobutyric acid (GABA) levels in autistic youngsters: stimulus for a GABA hypothesis of autism. Med. Sci. Monit. 8, PR1-PR6.
35. D'hulst, C., and Kooy, R. F. (2007). The GABAA receptor: a novel target for treatment of fragile X? Trends Neurosci. 30, 425-431. doi: 10.1016/j.tins.2007.06.003
36. Erol, I., Alehan, F., and Gümüs, A. (2007). West syndrome in an infant with vitamin B12 deficiency in the absence of macrocytic anaemia. Dev. Med. Child Neurol. 49, 774-776. doi: 10.1111/j.1469-8749.2007.00774.x
37. Fatemi, S. H. (2008). The hyperglutamatergic hypothesis of autism. Prog. Neuropsychopharmacol. Biol. Psychiatry. 32, 911. author reply: 912-913.
38. Fatemi, S. H., Reutiman, T. J., Folsom, T. D., and Thuras, P. D. (2009). GABA(A) receptor downregulation in brains of subjects with autism. J. Autism Dev. Disord. 39, 223-230. doi: 10.1007/s10803-008-0646-7
39. Favorov, O. V., and Kelly, D. G. (1994). Minicolumnar organization within somatosensory cortical segregates: II. Emergent functional properties. Cereb. Cortex 4, 428-442. doi: 10.1093/cercor/4.4.428
40. Frye, R. E. (2012a). Biomarker of abnormal energy metabolism in children with autism spectrum disorder. North Am. J. Med. Sci. 5, 141-147. doi: 10.7156/v5i3p141
41. Frye, R. E. (2012b). Mitochondrial disease in 22q13 duplication syndrome. J. Child Neurol. 27, 942-949. doi: 10.1177/0883073811429858
42. Frye, R. E. (2012c). Novel mitochondrial Cytochrome B gene polymorphisms associated with autism. J. Pediatr. Neurol. 10, 35-40. doi: 10.3233/JPN-2012-0530
43. Frye, R. E. (2014). Clinical potential, safety, and tolerability of arbaclofen in the treatment of autism spectrum disorder. Drug Healthc. Patient Saf. 6, 69-76. doi: 10.2147/DHPS.S39595
44. Frye, R. E. (2015). Metabolic and mitochondrial disorders associated with epilepsy in children with autism spectrum disorder. Epilepsy Behav. 47, 147-157. doi: 10.1016/j.yebeh.2014.08.134
45. Frye, R. E., Cox, D., Slattery, J., Tippett, M., Kahler, S., Granpeesheh, D., et al. (2016a). Mitochondrial Dysfunction may explain symptom variation in Phelan-McDermid Syndrome. Sci. Rep. 6, 19544. doi: 10.1038/srep19544
46. Frye, R. E., Delatorre, R., Taylor, H. B., Slattery, J., Melnyk, S., Chowdhury, N., et al. (2013a). Metabolic effects of sapropterin treatment in autism spectrum disorder: a preliminary study. Transl. Psychiatry 3:e237. doi: 10.1038/tp.2013.14
47. Frye, R. E., Delhey, L., Slattery, J., Tippett, M., Wynne, R., Rose, S., et al. (2016b). Blocking and binding folate receptor alpha autoantibodies identify novel autism spectrum disorder subgroups. Front. Neurosci. 10:80. doi: 10.3389/fnins.2016.00080
48. Frye, R. E., and James, S. J. (2014). Metabolic pathology of autism in relation to redox metabolism. Biomark. Med. 8, 321-330. doi: 10.2217/bmm.13.158
49. Frye, R. E., Melnyk, S., Fuchs, G., Reid, T., Jernigan, S., Pavliv, O., et al. (2013b). Effectiveness of methylcobalamin and folinic Acid treatment on adaptive behavior in children with autistic disorder is related to glutathione redox status. Autism Res. Treat. 2013, 609705. doi: 10.1155/2013/609705
50. Frye, R. E., and Naviaux, R. K. (2011). Autistic disorder with complex IV overactivity: a new mitochondrial syndrome. J. Pediatr. Neurol. 9, 427-434. doi: 10.3233/JPN-2011-0507
51. Frye, R. E., and Rossignol, D. A. (2011). Mitochondrial dysfunction can connect the diverse medical symptoms associated with autism spectrum disorders. Pediatr. Res. 69, 41R-47R. doi: 10.1203/pdr.0b013e318212f16b
52. Frye, R. E., Sequeira, J. M., Quadros, E. V., James, S. J., and Rossignol, D. A. (2013c). Cerebral folate receptor autoantibodies in autism spectrum disorder. Mol. Psychiatry 18, 369-381. doi: 10.1038/mp.2011.175
53. Fukahori, M., and Itoh, M. (1990). Effects of dietary zinc status on seizure susceptibility and hippocampal zinc content in the El (epilepsy) mouse. Brain Res. 529, 16-22. doi: 10.1016/0006-8993(90)90806-M
54. Furieri, L. B., Galán, M., Avendaño, M. S., García-Redondo, A. B., Aguado, A., Martínez, S., et al. (2011). Endothelial dysfunction of rat coronary arteries after exposure to low concentrations of mercury is dependent on reactive oxygen species. Br. J. Pharmacol. 162, 1819-1831. doi: 10.1111/j.1476-5381.2011.01203.x
55. Ganesh, R., and Janakiraman, L. (2008). Serum zinc levels in children with simple febrile seizure. Clin. Pediatr. 47, 164-166. doi: 10.1177/0009922807306165
56. Ganor, Y., Goldberg-Stern, H., Amrom, D., Lerman-Sagie, T., Teichberg, V. I., Pelled, D., et al. (2004). Autoimmune epilepsy: some epilepsy patients harbor autoantibodies to glutamate receptors and dsDNA on both sides of the blood-brain barrier, which may kill neurons and decrease in brain fluids after hemispherotomy. Clin. Dev. Immunol. 11, 241-252. doi: 10.1080/17402520400001736
57. Giulivi, C., Zhang, Y. F., Omanska-Klusek, A., Ross-Inta, C., Wong, S., Hertz-Picciotto, I., et al. (2010). Mitochondrial dysfunction in autism. JAMA 304, 2389-2396. doi: 10.1001/jama.2010.1706
58. Glushakov, A. V., Dennis, D. M., Sumners, C., Seubert, C. N., and Martynyuk, A. E. (2003). L-phenylalanine selectively depresses currents at glutamatergic excitatory synapses. J. Neurosci. Res. 72, 116-124. doi: 10.1002/jnr.10569
59. Glushakov, A. V., Glushakova, O., Varshney, M., Bajpai, L. K., Sumners, C., Laipis, P. J., et al. (2005). Long-term changes in glutamatergic synaptic transmission in phenylketonuria. Brain 128, 300-307. doi: 10.1093/brain/awh354
60. Gospe, S. M. (2002). Pyridoxine-dependent seizures: findings from recent studies pose new questions. Pediatr. Neurol. 26, 181-185. doi: 10.1016/S0887-8994(01)00407-6
61. Gospe, S. M. Jr., Olin, K. L., and Keen, C. L. (1994). Reduced GABA synthesis in pyridoxine-dependent seizures. Lancet 343, 1133-1134. doi: 10.1016/S0140-6736(94)90236-4
62. Grice, S. J., Spratling, M. W., Karmiloff-Smith, A., Halit, H., Csibra, G., De Haan, M., et al. (2001). Disordered visual processing and oscillatory brain activity in autism and Williams syndrome. Neuroreport 12, 2697-2700. doi: 10.1097/00001756-200108280-00021
63. Grothe, B., and Klump, G. M. (2000). Temporal processing in sensory systems. Curr. Opin. Neurobiol. 10, 467-473. doi: 10.1016/S0959-4388(00)00115-X
64. Hallak, M. (1998). Effect of parenteral magnesium sulfate administration on excitatory amino acid receptors in the rat brain. Magnes. Res. 11, 117-131.
65. Hallak, M., Berman, R. F., Irtenkauf, S. M., Evans, M. I., and Cotton, D. B. (1992). Peripheral magnesium sulfate enters the brain and increases the threshold for hippocampal seizures in rats. Am. J. Obstet. Gynecol. 167, 1605-1610. doi: 10.1016/0002-9378(92)91749-Z
66. Han, Y., Qin, J., Bu, D. F., Chang, X. Z., and Yang, Z. X. (2006). Successive alterations of hippocampal gamma-aminobutyric acid B receptor subunits in a rat model of febrile seizure. Life Sci. 78, 2944-2952. doi: 10.1016/j.lfs.2005.11.023
67. Hara, H. (2007). Autism and epilepsy: a retrospective follow-up study. Brain Dev. 29, 486-490. doi: 10.1016/j.braindev.2006.12.012
68. Heinemann, U., and Hamon, B. (1986). Calcium and epileptogenesis. Exp. Brain Res. 65, 1-10. doi: 10.1007/BF00243826
69. Hendren, R. L., James, S. J., Widjaja, F., Lawton, B., Rosenblatt, A., and Bent, S. (2016). Randomized, placebo-controlled trial of Methyl B12 for children with autism. J. Child Adolesc. Psychopharmacol. doi: 10.1089/cap.2015.0159. [Epub ahead of print].
70. Jakobs, C., Bojasch, M., Mönch, E., Rating, D., Siemes, H., and Hanefeld, F. (1981). Urinary excretion of gamma-hydroxybutyric acid in a patient with neurological abnormalities. The probability of a new inborn error of metabolism. Clin. Chim. Acta 111, 169-178. doi: 10.1016/0009-8981(81)90184-4
71. James, S. J., Melnyk, S., Fuchs, G., Reid, T., Jernigan, S., Pavliv, O., et al. (2009a). Efficacy of methylcobalamin and folinic acid treatment on glutathione redox status in children with autism. Am. J. Clin. Nutr. 89, 425-430. doi: 10.3945/ajcn.2008.26615
72. James, S. J., Rose, S., Melnyk, S., Jernigan, S., Blossom, S., Pavliv, O., et al. (2009b). Cellular and mitochondrial glutathione redox imbalance in lymphoblastoid cells derived from children with autism. FASEB J. 23, 2374-2383. doi: 10.1096/fj.08-128926
73. Jurecka, A., Zikanova, M., Tylki-Szymanska, A., Krijt, J., Bogdanska, A., Gradowska, W., et al. (2008). Clinical, biochemical and molecular findings in seven Polish patients with adenylosuccinate lyase deficiency. Mol. Genet. Metab. 94, 435-442. doi: 10.1016/j.ymgme.2008.04.013
74. Kalra, S., Burbelo, P. D., Bayat, A., Ching, K. H., Thurm, A., Iadarola, M. J., et al. (2015). No evidence of antibodies against GAD65 and other specific antigens in children with autism. BBA Clin. 4, 81-84. doi: 10.1016/j.bbacli.2015.08.001
75. Kang, J. Q., Shen, W., and Macdonald, R. L. (2009). Two molecular pathways (NMD and ERAD) contribute to a genetic epilepsy associated with the GABA(A) receptor GABRA1 PTC mutation, 975delC, S326fs328X. J. Neurosci. 29, 2833-2844. doi: 10.1523/JNEUROSCI.4512-08.2009
76. Karayannis, T., Au, E., Patel, J. C., Kruglikov, I., Markx, S., Delorme, R., et al. (2014). Cntnap4 differentially contributes to GABAergic and dopaminergic synaptic transmission. Nature 511, 236-240. doi: 10.1038/nature13248
77. Kriaucionis, S., Paterson, A., Curtis, J., Guy, J., Macleod, N., and Bird, A. (2006). Gene expression analysis exposes mitochondrial abnormalities in a mouse model of Rett syndrome. Mol. Cell. Biol. 26, 5033-5042. doi: 10.1128/MCB.01665-05
78. Kumar, S. (2004). Recurrent seizures: an unusual manifestation of vitamin B12 deficiency. Neurol. India 52, 122-123.
79. Li, L., Chin, L. S., Shupliakov, O., Brodin, L., Sihra, T. S., Hvalby, O., et al. (1995). Impairment of synaptic vesicle clustering and of synaptic transmission, and increased seizure propensity, in synapsin I-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 92, 9235-9239. doi: 10.1073/pnas.92.20.9235
80. Li, Z., Okamoto, K., Hayashi, Y., and Sheng, M. (2004). The importance of dendritic mitochondria in the morphogenesis and plasticity of spines and synapses. Cell 119, 873-887. doi: 10.1016/j.cell.2004.11.003
81. Lockitch, G., Berry, B., Roland, E., Wadsworth, L., Kaikov, Y., and Mirhady, F. (1991). Seizures in a 10-week-old infant: lead poisoning from an unexpected source. CMAJ 145, 1465-1468.
82. Longo, N., Ardon, O., Vanzo, R., Schwartz, E., and Pasquali, M. (2011). Disorders of creatine transport and metabolism. Am. J. Med. Genet. C Semin. Med. Genet. 157C, 72-78. doi: 10.1002/ajmg.c.30292
83. Macdermott, A. B., Mayer, M. L., Westbrook, G. L., Smith, S. J., and Barker, J. L. (1986). NMDA-receptor activation increases cytoplasmic calcium concentration in cultured spinal cord neurones. Nature 321, 519-522. doi: 10.1038/321519a0
84. Majoie, H. J., De Baets, M., Renier, W., Lang, B., and Vincent, A. (2006). Antibodies to voltage-gated potassium and calcium channels in epilepsy. Epilepsy Res. 71, 135-141. doi: 10.1016/j.eplepsyres.2006.06.003
85. Martynyuk, A. E., Glushakov, A. V., Sumners, C., Laipis, P. J., Dennis, D. M., and Seubert, C. N. (2005). Impaired glutamatergic synaptic transmission in the PKU brain. Mol. Genet. Metab. 86(Suppl. 1), S34-S42. doi: 10.1016/j.ymgme.2005.06.014
86. Mathern, G. W., Pretorius, J. K., Mendoza, D., Lozada, A., Leite, J. P., Chimelli, L., et al. (1998). Increased hippocampal AMPA and NMDA receptor subunit immunoreactivity in temporal lobe epilepsy patients. J. Neuropathol. Exp. Neurol. 57, 615-634. doi: 10.1097/00005072-199806000-00008
87. Mikuni, N., Babb, T. L., Ying, Z., Najm, I., Nishiyama, K., Wylie, C., et al. (1999). NMDA-receptors 1 and 2A/B coassembly increased in human epileptic focal cortical dysplasia. Epilepsia 40, 1683-1687. doi: 10.1111/j.1528-1157.1999.tb01584.x
88. Mills, P. B., Struys, E., Jakobs, C., Plecko, B., Baxter, P., Baumgartner, M., et al. (2006). Mutations in antiquitin in individuals with pyridoxine-dependent seizures. Nat. Med. 12, 307-309. doi: 10.1038/nm1366
89. Mollah, M. A., Rakshit, S. C., Anwar, K. S., Arslan, M. I., Saha, N., Ahmed, S., et al. (2008). Zinc concentration in serum and cerebrospinal fluid simultaneously decrease in children with febrile seizure: findings from a prospective study in Bangladesh. Acta Paediatr. 97, 1707-1711. doi: 10.1111/j.1651-2227.2008.01001.x
90. Mountcastle, V. B. (1997). The columnar organization of the neocortex. Brain 120(Pt 4), 701-722. doi: 10.1093/brain/120.4.701
91. Murdoch, J. D., and State, M. W. (2013). Recent developments in the genetics of autism spectrum disorders. Curr. Opin. Genet. Dev. 23, 310-315. doi: 10.1016/j.gde.2013.02.003
92. Obeid, R., Mccaddon, A., and Herrmann, W. (2007). The role of hyperhomocysteinemia and B-vitamin deficiency in neurological and psychiatric diseases. Clin. Chem. Lab. Med. 45, 1590-1606. doi: 10.1515/CCLM.2007.356
93. Pal, P. B., Pal, S., Das, J., and Sil, P. C. (2012). Modulation of mercury-induced mitochondria-dependent apoptosis by glycine in hepatocytes. Amino Acids 42, 1669-1683. doi: 10.1007/s00726-011-0869-3
94. Pearl, P. L., Gibson, K. M., Cortez, M. A., Wu, Y., Carter Snead, O. 3rd., Knerr, I., et al. (2009a). Succinic semialdehyde dehydrogenase deficiency: lessons from mice and men. J. Inherit. Metab. Dis. 32, 343-352. doi: 10.1007/s10545-009-1034-y
95. Pearl, P. L., Gibson, K. M., Quezado, Z., Dustin, I., Taylor, J., Trzcinski, S., et al. (2009b). Decreased GABA-A binding on FMZ-PET in succinic semialdehyde dehydrogenase deficiency. Neurology 73, 423-429. doi: 10.1212/WNL.0b013e3181b163a5
96. Pei, Y., Zhao, D., Huang, J., and Cao, L. (1983). Zinc-induced seizures: a new experimental model of epilepsy. Epilepsia 24, 169-176. doi: 10.1111/j.1528-1157.1983.tb04876.x
97. Pelc, K., Boyd, S. G., Cheron, G., and Dan, B. (2008). Epilepsy in Angelman syndrome. Seizure 17, 211-217. doi: 10.1016/j.seizure.2007.08.004
98. Peñagarikano, O., Abrahams, B. S., Herman, E. I., Winden, K. D., Gdalyahu, A., Dong, H., et al. (2011). Absence of CNTNAP2 leads to epilepsy, neuronal migration abnormalities, and core autism-related deficits. Cell 147, 235-246. doi: 10.1016/j.cell.2011.08.040
99. Pickett, J., Xiu, E., Tuchman, R., Dawson, G., and Lajonchere, C. (2011). Mortality in individuals with autism, with and without epilepsy. J. Child Neurol. 26, 932-939. doi: 10.1177/0883073811402203
100. Póo-Argüelles, P., Arias, A., Vilaseca, M. A., Ribes, A., Artuch, R., Sans-Fito, A., et al. (2006). X-Linked creatine transporter deficiency in two patients with severe mental retardation and autism. J. Inherit. Metab. Dis. 29, 220-223. doi: 10.1007/s10545-006-0212-4
101. Princivalle, A. P., Richards, D. A., Duncan, J. S., Spreafico, R., and Bowery, N. G. (2003). Modification of GABA(B1) and GABA(B2) receptor subunits in the somatosensory cerebral cortex and thalamus of rats with absence seizures (GAERS). Epilepsy Res. 55, 39-51. doi: 10.1016/S0920-1211(03)00090-1
102. Quiroz, J. A., Gray, N. A., Kato, T., and Manji, H. K. (2008). Mitochondrially mediated plasticity in the pathophysiology and treatment of bipolar disorder. Neuropsychopharmacology 33, 2551-2565. doi: 10.1038/sj.npp.1301671
103. Ramaekers, V. T., and Blau, N. (2004). Cerebral folate deficiency. Dev. Med. Child Neurol. 46, 843-851. doi: 10.1111/j.1469-8749.2004.tb00451.x
104. Ramaekers, V. T., Häusler, M., Opladen, T., Heimann, G., and Blau, N. (2002). Psychomotor retardation, spastic paraplegia, cerebellar ataxia and dyskinesia associated with low 5-methyltetrahydrofolate in cerebrospinal fluid: a novel neurometabolic condition responding to folinic acid substitution. Neuropediatrics 33, 301-308. doi: 10.1055/s-2002-37082
105. Riazi, K., Galic, M. A., and Pittman, Q. J. (2010). Contributions of peripheral inflammation to seizure susceptibility: cytokines and brain excitability. Epilepsy Res. 89, 34-42. doi: 10.1016/j.eplepsyres.2009.09.004
106. Rippon, G., Brock, J., Brown, C., and Boucher, J. (2007). Disordered connectivity in the autistic brain: challenges for the 'new psychophysiology'. Int. J. Psychophysiol. 63, 164-172. doi: 10.1016/j.ijpsycho.2006.03.012
107. Rose, C. (2006). Effect of ammonia on astrocytic glutamate uptake/release mechanisms. J. Neurochem. 97(Suppl. 1), 11-15. doi: 10.1111/j.1471-4159.2006.03796.x
108. Rose, S., Frye, R. E., Slattery, J., Wynne, R., Tippett, M., Melnyk, S., et al. (2014a). Oxidative stress induces mitochondrial dysfunction in a subset of autistic lymphoblastoid cell lines. Transl. Psychiatry 4:e377. doi: 10.1038/tp.2014.15
109. Rose, S., Frye, R. E., Slattery, J., Wynne, R., Tippett, M., Pavliv, O., et al. (2014b). Oxidative stress induces mitochondrial dysfunction in a subset of autism lymphoblastoid cell lines in a well-matched case control cohort. PLoS ONE 9:e85436. doi: 10.1371/journal.pone.0085436
110. Rose, S., Wynne, R., Frye, R. E., Melnyk, S., and James, S. J. (2015). Increased susceptibility to ethylmercury-induced mitochondrial dysfunction in a subset of autism lymphoblastoid cell lines. J. Toxicol. 2015, 573701. doi: 10.1155/2015/573701
111. Rossignol, D. A., and Frye, R. E. (2012a). Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis. Mol. Psychiatry 17, 290-314. doi: 10.1038/mp.2010.136
112. Rossignol, D. A., and Frye, R. E. (2012b). A review of research trends in physiological abnormalities in autism spectrum disorders: immune dysregulation, inflammation, oxidative stress, mitochondrial dysfunction and environmental toxicant exposures. Mol. Psychiatry 17, 389-401. doi: 10.1038/mp.2011.165
113. Rossignol, D. A., Genuis, S. J., and Frye, R. E. (2014). Environmental toxicants and autism spectrum disorders: a systematic review. Transl. Psychiatry 4:e360. doi: 10.1038/tp.2014.4
114. Rout, U. K., Mungan, N. K., and Dhossche, D. M. (2012). Presence of GAD65 autoantibodies in the serum of children with autism or ADHD. Eur. Child Adolesc. Psychiatry 21, 141-147. doi: 10.1007/s00787-012-0245-1
115. Rubenstein, J. L., and Merzenich, M. M. (2003). Model of autism: increased ratio of excitation/inhibition in key neural systems. Genes Brain Behav. 2, 255-267. doi: 10.1034/j.1601-183X.2003.00037.x
116. Sansa, G., Carlson, C., Doyle, W., Weiner, H. L., Bluvstein, J., Barr, W., et al. (2011). Medically refractory epilepsy in autism. Epilepsia 52, 1071-1075. doi: 10.1111/j.1528-1167.2011.03069.x
117. Schaefer, G. B., Mendelsohn, N. J., Professional, P., and Guidelines, C. (2013). Clinical genetics evaluation in identifying the etiology of autism spectrum disorders: 2013 guideline revisions. Genet. Med. 15, 399-407. doi: 10.1038/gim.2013.32
118. Schuler, V., Lüscher, C., Blanchet, C., Klíx, N., Sansig, G., Klebs, K., et al. (2001). Epilepsy, hyperalgesia, impaired memory, and loss of pre-and postsynaptic GABA(B) responses in mice lacking GABA(B(1)). Neuron 31, 47-58. doi: 10.1016/S0896-6273(01)00345-2
119. Shavelle, R. M., Strauss, D. J., and Pickett, J. (2001). Causes of death in autism. J. Autism Dev. Disord. 31, 569-576. doi: 10.1023/A:1013247011483
120. Shcheglovitov, A., Shcheglovitova, O., Yazawa, M., Portmann, T., Shu, R., Sebastiano, V., et al. (2013). SHANK3 and IGF1 restore synaptic deficits in neurons from 22q13 deletion syndrome patients. Nature 503, 267-271. doi: 10.1038/nature12618
121. Silbergeld, E. K., Miller, L. P., Kennedy, S., and Eng, N. (1979). Lead, GABA, and seizures: effects of subencephalopathic lead exposure on seizure sensitivity and GABAergic function. Environ. Res. 19, 371-382. doi: 10.1016/0013-9351(79)90062-8
122. Sinert, R., Zehtabchi, S., Desai, S., Peacock, P., Altura, B. T., and Altura, B. M. (2007). Serum ionized magnesium and calcium levels in adult patients with seizures. Scand. J. Clin. Lab. Invest. 67, 317-326. doi: 10.1080/00365510601051441
123. Specchio, N., Fusco, L., Claps, D., and Vigevano, F. (2010). Epileptic encephalopathy in children possibly related to immune-mediated pathogenesis. Brain Dev. 32, 51-56. doi: 10.1016/j.braindev.2009.09.017
124. Spiegel, E. K., Colman, R. F., and Patterson, D. (2006). Adenylosuccinate lyase deficiency. Mol. Genet. Metab. 89, 19-31. doi: 10.1016/j.ymgme.2006.04.018
125. Srivastava, A. K., and Schwartz, C. E. (2014). Intellectual disability and autism spectrum disorders: causal genes and molecular mechanisms. Neurosci. Biobehav. Rev. 46(Pt 2), 161-174. doi: 10.1016/j.neubiorev.2014.02.015
126. Su, H., Fan, W., Coskun, P. E., Vesa, J., Gold, J. A., Jiang, Y. H., et al. (2011). Mitochondrial dysfunction in CA1 hippocampal neurons of the UBE3A deficient mouse model for Angelman syndrome. Neurosci. Lett. 487, 129-133. doi: 10.1016/j.neulet.2009.06.079
127. Swartzwelder, H. S. (1985). Central neurotoxicity after exposure to organic lead: susceptibility to seizures. Neurosci. Lett. 58, 225-228. doi: 10.1016/0304-3940(85)90168-5
128. Tabuchi, K., Blundell, J., Etherton, M. R., Hammer, R. E., Liu, X., Powell, C. M., et al. (2007). A neuroligin-3 mutation implicated in autism increases inhibitory synaptic transmission in mice. Science 318, 71-76. doi: 10.1126/science.1146221
129. Tommerdahl, M., Tannan, V., Cascio, C. J., Baranek, G. T., and Whitsel, B. L. (2007). Vibrotactile adaptation fails to enhance spatial localization in adults with autism. Brain Res. 1154, 116-123. doi: 10.1016/j.brainres.2007.04.032
130. Torres, A. D., Rai, A. N., and Hardiek, M. L. (2000). Mercury intoxication and arterial hypertension: report of two patients and review of the literature. Pediatrics 105:E34. doi: 10.1542/peds.105.3.e34
131. Tuchman, R. (2013). Autism and social cognition in epilepsy: implications for comprehensive epilepsy care. Curr. Opin. Neurol. 26, 214-218. doi: 10.1097/WCO.0b013e32835ee64f
132. Tuchman, R. F., and Rapin, I. (1997). Regression in pervasive developmental disorders: seizures and epileptiform electroencephalogram correlates. Pediatrics 99, 560-566. doi: 10.1542/peds.99.4.560
133. Tuchman, R., Hirtz, D., and Mamounas, L. A. (2013). NINDS epilepsy and autism spectrum disorders workshop report. Neurology 81, 1630-1636. doi: 10.1212/WNL.0b013e3182a9f482
134. Tuchman, R., and Rapin, I. (2002). Epilepsy in autism. Lancet Neurol. 1, 352-358. doi: 10.1016/S1474-4422(02)00160-6
135. Vargas, D. L., Nascimbene, C., Krishnan, C., Zimmerman, A. W., and Pardo, C. A. (2005). Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann. Neurol. 57, 67-81. doi: 10.1002/ana.20315
136. Vincent, A., Buckley, C., Schott, J. M., Baker, I., Dewar, B. K., Detert, N., et al. (2004). Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. Brain 127, 701-712. doi: 10.1093/brain/awh077
137. Volkmar, F. R., and Nelson, D. S. (1990). Seizure disorders in autism. J. Am. Acad. Child Adolesc. Psychiatry 29, 127-129. doi: 10.1097/00004583-199001000-00020
138. Waldbaum, S., and Patel, M. (2010). Mitochondria, oxidative stress, and temporal lobe epilepsy. Epilepsy Res. 88, 23-45. doi: 10.1016/j.eplepsyres.2009.09.020
139. Wang, L., Wang, H., Li, J., Chen, D., and Liu, Z. (2011a). Simultaneous effects of lead and cadmium on primary cultures of rat proximal tubular cells: interaction of apoptosis and oxidative stress. Arch. Environ. Contam. Toxicol. 61, 500-511. doi: 10.1007/s00244-011-9644-4
140. Wang, X., Mccoy, P. A., Rodriguiz, R. M., Pan, Y., Je, H. S., Roberts, A. C., et al. (2011b). Synaptic dysfunction and abnormal behaviors in mice lacking major isoforms of Shank3. Hum. Mol. Genet. 20, 3093-3108. doi: 10.1093/hmg/ddr212
141. Williams, R. A., Mamotte, C. D., and Burnett, J. R. (2008). Phenylketonuria: an inborn error of phenylalanine metabolism. Clin. Biochem. Rev. 29, 31-41.
142. Williamson, A., and Spencer, D. (1995). Zinc reduces dentate granule cell hyperexcitability in epileptic humans. Neuroreport 6, 1562-1564. doi: 10.1097/00001756-199507310-00024
143. Zablotsky, B., Black, L. I., Maenner, M. J., Schieve, L. A., and Blumberg, S. J. (2015). Estimated Prevalence of Autism and Other Developmental Disabilities Following Questionnaire Changes in the 2014 National Health Interview Survey. Hyattsville, MD: National Center for Health Statistics. National Health Statistics Reports No. 87.